GILD (STOCKS)
Gilead Sciences Inc
$139.030000
+0.040000 (+0.03%)
Prev close: $138.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel P. O'Day
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $172,579.52M
- Employees
- 17,600
- P/E (TTM)
- 20.50
- P/B (TTM)
- 7.60
- Dividend Yield
- 229.51%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
20
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.86 | $1.85 | +0.0134 | +0.73% |
|
Sep 2025 (Q3)
|
$2.47 | $2.17 | +0.2972 | +13.68% |
|
Jun 2025 (Q2)
|
$2.01 | $2.00 | +0.0120 | +0.60% |
|
Mar 2025 (Q1)
|
$1.81 | $1.82 | -0.0107 | -0.59% |
Financial Statements
| Revenues | $29.44B |
| Benefits Costs and Expenses | $19.65B |
| Cost Of Revenue | $6.23B |
| Costs And Expenses | $19.42B |
| Gross Profit | $23.21B |
| Nonoperating Income/Loss | $798.00M |
| Operating Expenses | $13.19B |
| Selling, General, and Administrative Expenses | $5.77B |
| Other Operating Expenses | $7.41B |
| Operating Income/Loss | $10.02B |
| Income/Loss From Continuing Operations After Tax | $8.51B |
| Income/Loss From Continuing Operations Before Tax | $9.80B |
| Income Tax Expense/Benefit | $1.29B |
| Income Tax Expense/Benefit, Deferred | $160.00M |
| Net Income/Loss | $8.51B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $8.51B |
| Net Income/Loss Available To Common Stockholders, Basic | $8.51B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.84 |
| Diluted Earnings Per Share | $6.78 |
| Basic Average Shares | 1,244,000,000 |
| Diluted Average Shares | 1,255,000,000 |
| Assets | $59.02B |
| Current Assets | $18.34B |
| Inventory | $1.77B |
| Other Current Assets | $16.57B |
| Noncurrent Assets | $40.68B |
| Fixed Assets | $5.61B |
| Intangible Assets | $16.98B |
| Other Non-current Assets | $18.10B |
| Liabilities | $36.41B |
| Current Liabilities | $11.81B |
| Accounts Payable | $715.00M |
| Wages | $1.30B |
| Other Current Liabilities | $9.80B |
| Noncurrent Liabilities | $24.59B |
| Long-term Debt | $24.94B |
| Equity | $22.62B |
| Equity Attributable To Noncontrolling Interest | -$84.00M |
| Equity Attributable To Parent | $22.70B |
| Liabilities And Equity | $59.02B |
| Net Cash Flow From Operating Activities | $10.02B |
| Net Cash Flow From Operating Activities, Continuing | $10.02B |
| Net Cash Flow From Investing Activities | -$4.79B |
| Net Cash Flow From Investing Activities, Continuing | -$4.79B |
| Net Cash Flow From Financing Activities | -$7.75B |
| Net Cash Flow From Financing Activities, Continuing | -$7.75B |
| Exchange Gains/Losses | $92.00M |
| Net Cash Flow | -$2.43B |
| Net Cash Flow, Continuing | -$2.52B |
| Comprehensive Income/Loss | $8.42B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $8.42B |
| Other Comprehensive Income/Loss | -$93.00M |